(Total Views: 603)
Posted On: 07/05/2020 12:58:16 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Coocooburra #41082
I believe that NP was referring to an “interim analysis” on the s/c trial which could be done on a timeline concurrent with a “non-delayed” m/m time line. Yes, the FDA could allow this and still require the s/c to progress till it concludes with the full 390 patients. Only time will tell.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)